Logo-bi
Original Research
Hamed Hamishehkar, Soheila Hosseini, Abdolhossein Naseri, Azam Safarnejad, Farzaneh Rasoulzadeh*
Bioimpacts. 2016;6(3): 125-133. doi: 10.15171/bi.2016.19
PMCID: PMC5108985     PMID: 27853676     Scopus ID: 85003815216    
Original Research
Yousef Sohrabi, Vahid Panahi-Azar, Abolfazl Barzegar, Jafar Ezzati Nazhad Dolatabadi* ORCID, Parvin Dehghan*
Bioimpacts. 2017;7(4): 241-246. doi: 10.15171/bi.2017.28
PMCID: PMC5801535     PMID: 29435431     Scopus ID: 85041015250    
Mini Review
Prasenjit Mondal, Adity Bose* ORCID
Bioimpacts. 2019;9(2): 115-121. doi: 10.15171/bi.2019.15
PMCID: PMC6637219     PMID: 31334043     Scopus ID: 85067495268    
Interaction of Quercetin and its Cu2+ complexes with serum albumins was studied. Complexation with Cu2+ altered the mode of binding of Qu with SAs, and strength of binding increased as evident from the binding constant calculation.
Original Article
Samira Gholizadeh ORCID, Hossein Haghaei, Hosna Karami, Somaieh Soltani* ORCID, Mostafa Zakariazadeh, Javad Shokri
Bioimpacts. 2023;13(2): 109-121. doi: 10.34172/bi.2022.23383
PMCID: PMC10182447     PMID: 37193080     Scopus ID: 85152094869    
Interaction of the Fingolimod with HSA was studied using multi-spectroscopic and molecular modeling methods. Fingolimod binds to the binding site II of HSA via hydrogen bonds and Van der Walls forces. The binding is enthalpy driven. Fingolimod interaction with HSA leads to the conformational change of HSA.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge